About the Startup
PROVIREX is focused on developing a modular gene therapy platform to target retroviruses like HTLV-1.
Frequently Asked Questions
What type of funding round did PROVIREX Genome Editing Therapies GmbH raise?
PROVIREX Genome Editing Therapies GmbH raised a unspecified round.
How much did PROVIREX Genome Editing Therapies GmbH raise in its unspecified?
PROVIREX Genome Editing Therapies GmbH raised $1,700,000 USD in its unspecified.
When did PROVIREX Genome Editing Therapies GmbH raise its unspecified?
PROVIREX Genome Editing Therapies GmbH raised its unspecified on 2025-07-30.
Who invested in PROVIREX Genome Editing Therapies GmbH's unspecified?
The investors in PROVIREX Genome Editing Therapies GmbH's unspecified are: BIOVENTURE Consulting GmbH, IFB Hamburg.
What type of investment was PROVIREX Genome Editing Therapies GmbH's unspecified?
PROVIREX Genome Editing Therapies GmbH's unspecified was a equity investment.